Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
#vangaurd 192k+ shares 5/29 $5.39 average
More avenues to come in the future! https://hightimes.com/study/study-aims-to-determine-role-of-shrooms-in-battling-alcoholism/
The trial will study Filament's botanical psilocybin drug candidate, PEX010.
Jaguar Health is about to be a powerhouse pharma company! Many avenues! More than dog shit!
as wolf of wall street would say..... IM NOT FKN SELLING
get ready boys
1B marketcap = SP of $203.80.
10B = $2038
100B = $203,800
Look at the marketcaps of Johnson and Johnson, Pfizer, Eli Lilly, etc, etc, they are in the BILLIONS
gauranteed they been sitting on this news today, pre split, along with the p3 results. the sponser is NAPO and that guy is Pravin Chatervidi
https://asco24.myexpoonline.com/exhibitors/exhibitor/779 kind of strange that they took the "make cancer less shitty" banner off and went with the Gelcair banner... I dont think we are going to see p3 at the conference, Gelcair is going to be the big news at ASCO and then p3 will be released either during a presentation or late abstract submission day of presentation... idk i could be wrong but either way with todays news this takes JAGX up as well. I think they want investors confused...
major move incoming ....... imminent ph3 ASCO #GELCAIR #CROFOLEMER #DIARRYEAH!!!!! first pt now $250 cause my old pt post r/s was 8-9$
#vangaurd 192k+ shares 5/29 $5.39 average
Investigator-Initiated Trial of Jaguar Health’s Crofelemer Yields Positive Results for Functional Diarrhea
MAY 23, 2024 at 5:00 PM (ET)
Majority of abstracts are released on asco.org/abstracts (Late-breaking Abstracts will be released at 7:00 AM CT on their day of presentation at the meeting)
MAY 31 - JUNE 4, 2024
ASCO Annual Meeting (Chicago, IL)
Well the EMAIL literally said phase 3 results are imminent, and lisa signed off the letter with "ALL THE BEST"
The number of shares of our common stock to be outstanding after this offering is based on 4,889,226 shares of our voting common stock and no shares of our non-voting common stock outstanding as of May 15, 2024, and excludes the following:
•
76,198 shares of common stock issuable upon exercise of warrants outstanding, with a weighted-average exercise price of $38.69;
?
•
435 shares of common stock issuable upon exercise of outstanding options under the 2014 Stock Incentive Plan, with a weighted-average exercise price of $36,701;
?
•
25 shares of common stock issuable upon exercise of outstanding options under the 2020 Employee Inducement Plan, with a weighted-average exercise price of $20,770;
?
•
63,637 shares of common stock that remain available for grant under the 2014 Stock Incentive Plan and 8,084 shares of common stock that remain available under the 2020 Employee Inducement Plan; and
?
•
44,801 and 175 shares of common stock issuable upon vesting of outstanding restricted stock unit awards (“RSUs”) under the 2014 Stock Incentive Plan and 2020 Employee Inducement Plan, respectively;
no big drop buy when scared
we are currently 367% off the lows in February, almost the time people bailed on the stock. We had a huge 255% move off the bottom in a few days, I wonder if we can get a 500-1000% move off news 🥰
.64c then $1.15 then $3.05, then moon
10th Annual Elite Ped-GI Congress, which takes place May 2-4, 2024 in Abu Dhabi in the United Arab Emirates (UAE)
WONDER IF WE HEAR ANYTHING BACK ON THIS TODAY???
ANIMALS AND HUMANS..... YOU MUST BE NEW......
Jaguar Health Applies for Investigational New Animal Drug Status for Potential Dog Diarrhea Treatment
REUTERS
Crofelemer, Jaguar Health’s Prescription Drug Conditionally Approved by the FDA for Chemotherapy-Induced Diarrhea in Dogs, is the Subject of the Company’s Investigational New Animal Drug Application for the Indication of General Diarrhea in Dogs
.40c next resistance level
THEM OLD TIMERS HAVE FLIGHT OR FIGHT MODE I LOVE TROLLING THOSE CORTISOL LEVELS SO MUCH
IM TROLLING FOR FUNSIES, AND I POST FACTS. I DONT CARE WHAT AN ACTAUL PERSON THINKS IN HERE. IM THE ONE WHO SAID A PARTNERSHIP WAS COMING.
there's actually 4 proposals we are voting on. I'm voting FOR R/S this retard spamming our board thinks we dont know thats coming lmao.
your a clown show lmao
hes literally either a crackhead or trolling you
YOU ARE LOST TRENDTRADE, NOBODY EVEN RESPONDS TO YOUR LOW IQ
You obviously haven't done this before.
Because he's been exposed by a troll lmao
The Agreement will cover Jaguar's FDA-approved indication of crofelemer (trade name Mytesi®) for HIV-related diarrhea and all potential crofelemer follow-on indications, including cancer therapy-related diarrhea - the subject of Jaguar's placebo-controlled pivotal Phase 3 OnTarget trial, as well as the rare disease indications short bowel syndrome (SBS) and microvillus inclusion disease (MVID), and any other possible future human indications for crofelemer.
Only up from here boys n girls
told yall :)
The Agreement will cover Jaguar's FDA-approved indication of crofelemer (trade name Mytesi®) for HIV-related diarrhea and all potential crofelemer follow-on indications, including cancer therapy-related diarrhea - the subject of Jaguar's placebo-controlled pivotal Phase 3 OnTarget trial, as well as the rare disease indications short bowel syndrome (SBS) and microvillus inclusion disease (MVID), and any other possible future human indications for crofelemer.
I'm holding 100k shares old timer
the shorts are scrambling, they are so fucked come earnings 🤣😂
sit back and watch this leave you behind old timer, a stock can still go up and they still inact a RS it doesnt matter